Source: MarketScreener

Leap Therapeutics: Leap Therapeutics : to Present at H.C. Wainwright 22nd Annual Global Investment Conference

(marketscreener.com) CAMBRIDGE, Mass., Sept. 9, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 22nd Annual Global Investment Conference,...https://www.marketscreener.com/quote/stock/LEAP-THERAPEUTICS-INC-33375941/news/Leap-Therapeutics-to-Present-at-H-C-Wainwright-22nd-Annual-Global-Investment-Conference-31257287/?utm_medium=RSS&utm_content=20200909

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more